Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of ANPEP monoclonal antibody, clone 22A5 (PE)
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Mouse |
| Applications | IP,IHC-Fr,Flow Cyt |
More info about ANPEP monoclonal antibody, clone 22A5 (PE)
| Brand: | Abnova |
| Reference: | MAB6039 |
| Product name: | ANPEP monoclonal antibody, clone 22A5 (PE) |
| Product description: | Mouse monoclonal antibody raised against ANPEP. |
| Clone: | 22A5 |
| Isotype: | IgG2a |
| Gene id: | 290 |
| Gene name: | ANPEP |
| Gene alias: | APN|CD13|LAP1|PEPN|gp150|p150 |
| Gene description: | alanyl (membrane) aminopeptidase |
| Immunogen: | Cell suspension containing osteoclasts from human osteoclastomas. |
| Form: | Liquid |
| Recommend dilutions: | Flow Cytometry (10 ul/106 cells) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS (0.09% sodium azide) |
| Storage instruction: | Store in the dark at 4°C. Do not freeze. Avoid prolonged exposure to light. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Conjugate tag: | PE |
| Product type: | Primary antibodies |
| Host species: | Mouse |
| Antigen species / target species: | Human |
| Specificity: | Specificity human CD13 |
| Reactivity: | Human |
| Applications: | IP,IHC-Fr,Flow Cyt |
| Shipping condition: | Blue Ice |
| Publications: | 1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation.Dang NH, Torimoto Y, Shimamura K, Tanaka T, Daley JF, Schlossman SF, Morimoto C. J Immunol. 1991 Nov 1;147(9):2825-32. |